-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: Partnering
Putting a Ring on It: Advice on Successful Drug Development Collaborations
Drug development partnerships can look lucrative to small biotechs eager to monetize their discoveries, but, like any relationship, these tie-ups take work and both parties run the risk of ending up in tears. At BIO’s recent CEO & Investor Conference, a panel of industry veterans gathered to discuss best practices in drug development partnering. Moderated by Jeff Stewart, Senior Engagement Manager with Campbell Alliance, the panel “Putting a Ring on it: When Drug Development Partnerships Read More >
The Year Ahead for Business Development Events
2013 is officially here (insert stale End-of-the-World joke). And as such, planning has been in full effect for BIO events. Here’s a recap of what’s coming up in the next few months. BIO’s in San Fran for JPM As a BIO member service, companies can schedule private meeting space for free during JP Morgan. This year, meetings will take place at The Palace Hotel, on the 5th floor. You can also find Celia, Dave, Kirsten Read More >
Harder, Better, Faster, Stronger: Takeaways from Partnering For Cures 2012
The chorus to Kanye West’s 2007 chart-topper Stronger can teach us volumes about speeding drug development. Harder: Drug development is challenging. It takes over 10 years and more than $1 billon to bring a therapy through the product pipeline, from the research lab to clinical trials to FDA approval to prescription to patients suffering from the disease. The FDA approved over 30 innovative drugs last year, including more than 10 new treatments for cancer—a good Read More >
Some ABCs of PAGs
A lot of people, and especially those who have attended BIO events (such as the BIO CEO & Investor Conference, BIO Investor Forum, and the BIO Business Forum) are familiar with the names Michael J. Fox Foundation, FasterCures, ALS Therapy Development Institute, JDRF, and other non-profit Patient Advocacy Groups, or “PAG’s”. In case you missed them, two blog posts came up from the Michael J. Fox Foundation and FasterCures that we wanted to share. They Read More >
What BIO2012 Meant to Boston and the Netherlands
We came across this recent post in Boston.com about the BIO International Convention and BIO Business Forum. It’s not just a recap of the event, but it’s a specific piece on one company’s goals, connecting Boston with the Netherlands. As you know, the BIO One-on-One Partnering System is open and accessible to attendees well after the conference shuts down and everyone goes home. This allows you to do your follow-up: go through your Inbox, research Read More >
